IL105061A - Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof - Google Patents
Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereofInfo
- Publication number
- IL105061A IL105061A IL10506193A IL10506193A IL105061A IL 105061 A IL105061 A IL 105061A IL 10506193 A IL10506193 A IL 10506193A IL 10506193 A IL10506193 A IL 10506193A IL 105061 A IL105061 A IL 105061A
- Authority
- IL
- Israel
- Prior art keywords
- fragments
- treatment
- pharmaceutical compositions
- neurodegenerative diseases
- vip analogues
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL10506193A IL105061A (en) | 1993-03-16 | 1993-03-16 | Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof |
EP94103479A EP0620008B1 (de) | 1993-03-16 | 1994-03-08 | Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten |
DE69418931T DE69418931T2 (de) | 1993-03-16 | 1994-03-08 | Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten |
TW083101988A TW290458B (de) | 1993-03-16 | 1994-03-08 | |
CNB941048179A CN1140294C (zh) | 1993-03-16 | 1994-03-15 | 血管活性肠肽其类似物及片段用于治疗神经变性疾病 |
KR1019940005069A KR100305453B1 (ko) | 1993-03-16 | 1994-03-15 | Vip,또는그의유사체,유도체또는단편으로이루어지는제약조성물 |
JP6084194A JPH0769919A (ja) | 1993-03-16 | 1994-03-16 | Vip,その類縁体またはそのフラグメントを含む医薬組成物 |
US08/413,708 US5972883A (en) | 1993-03-16 | 1995-03-30 | Method for the treatment of neurodegenerative diseases by administering VIP, an analogue, fragment or a conjugate thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL10506193A IL105061A (en) | 1993-03-16 | 1993-03-16 | Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
IL105061A0 IL105061A0 (en) | 1993-07-08 |
IL105061A true IL105061A (en) | 2000-11-21 |
Family
ID=11064619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10506193A IL105061A (en) | 1993-03-16 | 1993-03-16 | Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0620008B1 (de) |
JP (1) | JPH0769919A (de) |
KR (1) | KR100305453B1 (de) |
CN (1) | CN1140294C (de) |
DE (1) | DE69418931T2 (de) |
IL (1) | IL105061A (de) |
TW (1) | TW290458B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL118003A0 (en) | 1996-04-23 | 1996-08-04 | Yeda Res & Dev | Novel vip fragments and pharmaceutical compositions comprising them |
FR2775902B1 (fr) * | 1998-03-13 | 2001-05-11 | Assist Publ Hopitaux De Paris | Utilisation d'analogues du vip dans la prevention et le traitement des lesions cerebrales du nouveau-ne humain |
US6713445B1 (en) * | 1998-04-06 | 2004-03-30 | Advanced Immuni T, Inc. | Peptides for treatment of HIV infection |
WO2002016430A2 (en) * | 2000-08-24 | 2002-02-28 | Thomas Jefferson University | Peptide with effects on cerebral health |
JP2004514697A (ja) | 2000-11-28 | 2004-05-20 | モンドバイオテック・ソシエテ・アノニム | 肺及び細動脈高血圧症治療用の血管作動性腸管ペプチドの生物学的活性をもつ化合物 |
EP1515745B1 (de) * | 2002-06-10 | 2009-03-18 | MondoBIOTECH Licensing Out AG | Verwendung von zusammensetzungen mit der biologischen aktivität der vasoaktiven intestinalen peptide zur behandlung von sarcoidose |
WO2008054498A2 (en) * | 2006-04-07 | 2008-05-08 | The Board Of Trustees Of The University Of Illinois | Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders |
KR101242066B1 (ko) | 2010-05-19 | 2013-03-12 | 강원대학교산학협력단 | Vip를 유효성분으로 함유하는 기분장애 예방 및 치료용 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9166291A (en) * | 1990-12-21 | 1992-07-22 | Case Western Reserve University | Neuronal cholinergic differentiation factor |
IL99924A (en) * | 1991-10-31 | 1995-12-31 | Yeda Res & Dev | Derivatives of structurally modified vip and pharmaceutical compositions containing them |
-
1993
- 1993-03-16 IL IL10506193A patent/IL105061A/xx not_active IP Right Cessation
-
1994
- 1994-03-08 EP EP94103479A patent/EP0620008B1/de not_active Expired - Lifetime
- 1994-03-08 TW TW083101988A patent/TW290458B/zh active
- 1994-03-08 DE DE69418931T patent/DE69418931T2/de not_active Expired - Fee Related
- 1994-03-15 CN CNB941048179A patent/CN1140294C/zh not_active Expired - Fee Related
- 1994-03-15 KR KR1019940005069A patent/KR100305453B1/ko not_active IP Right Cessation
- 1994-03-16 JP JP6084194A patent/JPH0769919A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL105061A0 (en) | 1993-07-08 |
TW290458B (de) | 1996-11-11 |
DE69418931T2 (de) | 2000-03-16 |
KR100305453B1 (ko) | 2001-11-22 |
JPH0769919A (ja) | 1995-03-14 |
CN1100327A (zh) | 1995-03-22 |
KR940021074A (ko) | 1994-10-17 |
EP0620008A1 (de) | 1994-10-19 |
EP0620008B1 (de) | 1999-06-09 |
CN1140294C (zh) | 2004-03-03 |
DE69418931D1 (de) | 1999-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
FI972433A0 (fi) | Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia | |
GB8900678D0 (en) | Compositions for the prevention and medical treatment of parodonthopathy | |
IL125446A0 (en) | Pharmaceutical composition for the treatment of asthma allergy and inflammation | |
LT96148A (en) | Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction | |
HU9402709D0 (en) | Pentofixillin for producing pharmaceutical compositions for treating lung diseases of granuloma and fibrozis | |
IL105061A (en) | Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof | |
IL119225A (en) | Pharmaceutical compositions for the treatment of asthma in mammals | |
HUP0003244A3 (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof | |
ZA9711129B (en) | New analogues of camptothecin their medical application and the pharmaceutical substances that contain them | |
ZA941088B (en) | Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them | |
HUP9901303A3 (en) | A pharmaceutical composition for the treatment of autoimmune diseases | |
IL121329A (en) | Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides | |
EP0362162A3 (en) | Pharmaceutical composition comprising zidovudine and inosiplex or components thereof for the treatment of aids and aids-related syndromes | |
AU6527390A (en) | Pharmaceutical compositions for the treatment of ataxy and equilibrium problems | |
IL109235A0 (en) | Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases | |
EP0796105A4 (de) | Pharmazeutische zusammensetzung zur behandlung von autoimmun krankheiten mit dem b-oligomer des pertussis toxin oder untereinheiten davon | |
GB9304745D0 (en) | Use of pharmaceutical formulations | |
AP9700928A0 (en) | Pharmaceutical compositions for the prevention or treatment of retrovirus infections | |
IL105690A0 (en) | Pharmaceutical compositions for the treatment of arrhythmia | |
ZA944671B (en) | Medicaments for the treatment of inflammatory diseases | |
IL109414A0 (en) | Pharmaceutical compositions containing sabeluzole for the treatment of chronic neurodegenerative diseases | |
HU9802142D0 (en) | Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system | |
GB9413939D0 (en) | Pharmaceutical composition for the treatment of chronic skin ulcers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |